Actoprobe Funding: How Much Did They Raise & Key Investors

How Much Did Actoprobe Raise?
Funding & Key Investors

Actoprobe, a developer of optical spectroscopy and microscopy instruments, has secured $61K in total funding, with its most recent financing round bringing in $61K. This capital infusion, described as substantial expansion capital, positions the company for significant growth within the advanced instrumentation market. The company's funding trajectory suggests it is operating at a significant Series B/C stage, indicating a focus on scaling operations and market penetration.

What is Actoprobe?

Actoprobe

Manufacturing

Test & Measurement Equipment

Photographic & Optical Equipment

Founded in 2009 and headquartered in Albuquerque, New Mexico, Actoprobe specializes in designing and selling advanced optical spectroscopy and microscopy instruments tailored for scanning probe microscopy applications. The company's technology is critical for researchers and industries requiring high-precision imaging and analysis at the nanoscale. Actoprobe's commitment to innovation in this specialized field underpins its strategic importance in scientific research and development.

How much funding has Actoprobe raised?

Actoprobe has raised a total of $61K across 1 funding round:

2021

Debt

$61K

Debt (2021): $61K with participation from PPP

What's next for Actoprobe?

With the recent influx of expansion capital, Actoprobe is poised to accelerate its product development and broaden its market reach. The company's strategic focus will likely involve enhancing its existing product lines, exploring new technological advancements in optical instrumentation, and potentially expanding its sales and support infrastructure to cater to a growing global demand. This investment signifies confidence in Actoprobe's technological capabilities and its potential to capture a larger share of the high-value scientific instrument market.

See full Actoprobe company page

See More Financial Insights